{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-256710","form_type":"8-K","ticker":"TYRA","cik":"0001863127","company_name":"Tyra Biosciences, Inc.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.824469+00:00","generated_at":"2026-06-23T06:07:20.639039+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tyra Biosciences enters $150M ATM equity offering facility with Virtu Americas","bullets":["Company may sell up to $150M of common stock at prevailing market prices through Agent Virtu Americas LLC.","Agent receives commission up to 3.0% of gross proceeds; no obligation for Company to sell any shares.","Shares issued under shelf registration statement filed with SEC on October 3, 2022.","Either party may terminate the Sales Agreement at any time on prior written notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-256710","json":"https://secwatch.observer/filing/0001193125-22-256710.json","markdown":"https://secwatch.observer/filing/0001193125-22-256710.md","text":"https://secwatch.observer/filing/0001193125-22-256710.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1863127/000119312522256710/0001193125-22-256710-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1863127/000119312522256710/d378227d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:07:20.639039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}